Medical System Network (4350) · InitiativeDropped
Turnaround of the SMO business
First written in FY2016. 1 of 3 entries say "Reframed", first in FY2017. Latest entry: FY2018.
3entries
3years
0from disclosures
How it moved
Same theme, other companies
Expansion and transfer of the SMO business structure, supported facilities and target areasA theme 2 companies write about · 1 as a headwind · 2 as a tailwind
1 other company's latest entry also says "Dropped".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2018DroppedAnnual report
「Effective 21 June 2017, we transferred all shares of 株式会社エスエムオーメディシス, formerly a consolidated subsidiary engaged in clinical trial site management services.」
The disclosure describes the discontinuation of the clinical trial site management services company after the transfer of all its shares, rather than a turnaround of the SMO business. - FY2017ReframedAnnual report
「On 16 June 2017, we entered into an agreement with 株式会社ＥＰ綜合 to transfer all shares of 株式会社エスエムオーメディシス, and the transfer was completed on 21 June 2017.」
Regarding the previous theme of turning around the SMO business, the report describes the SMO subsidiary ceasing to be a subsidiary through the transfer of all its shares. The reason for the transfer is not stated and should not be inferred. - FY2016First statedAnnual report
「Turnaround of the SMO business (site management organization services for clinical trials)」
The company cited developing partner medical institutions, primarily large hospitals, securing orders, mutual referrals with partners, and personnel exchanges and training.